Avastin dilemma accusing normal ophthalmologists for criminals
‘Avastin(generic name: bevacizumab),’ which has been widely used without approval as the age-related macular degeneration treatment, has been in a dilemma.
Recently, an ophthalmologist who injected Avastin to treat macular degeneration was close to be accused by a private insurance company and r...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
